The study demonstrates the tissue sparing benefits of proton therapy over photon therapy for Ewings sarcomas in the pelvis and thoracic spine.
Purpose/Objective: The objective of the study was to compare intensity modulated radiotherapy (IMRT) and intensity modulated proton therapy (IMPT) for locally advanced cervical cancer in terms of dose-volume parameters, dose coverage and conformity. Furthermore, to study the effect of reduced margins. Materials and Methods: External beam radiotherapy planning of the pelvic region was carried out for 5 patients with locally advanced cervical cancer. Planning target volume (PTV) was defined by primary tumour, pelvic and regional lymph nodes. Dose prescription was 50.4 Gy in 28 fractions. PTV dose coverage criteria was set to D98% 95%. Two sets of treatment plans were prepared based on different CTV-PTV margins: clinical margin ( 7 mm L-R, 10 mm S-I, 15 mm A-P) and reduced margin (7 mm isotropic). The IMRT and IMPT plans were generated using the Eclipse treatment planning system. Dose-volume histograms (DVHs) were analyzed for the PTV and various organs at risk (OARs; rectum, bladder, bowel, sigmoideum and pelvic bone). Student's t-test was used for all statistical comparison. Results: All IMRT and IMPT plans covered 98% of PTV with 95% isodose, so the dose prescription was well achieved. IMPT demonstrated the potential in sparing doses to OARs, where significant differences were seen compared to IMRT for many dose-volume parameters (table 1). Concerning the reduced margins, increased differences between IMPT and IMRT were seen for the bladder (data not shown). However, for the high dose regions in bowel and sigmoideum the potential sparing by IMPT was found to be less with reduced margins. Purpose/Objective: Modern commercial treatment planning systems (TPS) become increasingly more flexible for research through the exposure of scripting APIs (Application Programming Interfaces). RayStation (RaySearch) even allows write access to the internal model in a controlled manner. However such APIs are limited to the structure of the TPS in terms of e.g. workflow and model assumptions. We have developed the in-house research TPS Dynaplan to facilitate the development of real-time interactive IMRT treatment planning. It is programmed in C++, tapping the power from parallel hardware architectures and optimised memory management. Often the development of in-house research software does not comply with medical device software standards like the software life cycle process (IEC 62304). We propose a solution that has the potential to mitigate the risks involved with in-house developed software by interfacing to the script client from RayStation. Materials and Methods: RayStation provides a scripting API through IronPython, which is part of .NET (Microsoft). As IronPython cannot be accessed through native C++ code, we have developed an interface called NativeRaystationConnect (NRC) as DLL, which converts native C++ into managed
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